The coexistence of PHF6 and JAK3 mutations in T-ALL patients was frequently noted, but little is known of the mechanism whereby PHF6 mutations promoted JAK3-driven T-cell leukemia. The gene discussed is JAK3; the disease is acute lymphoblastic leukemia.